Skip to content

Active ingredient

Bendamustine

16 finished FDA listings contain Bendamustine as their only active ingredient.

FDA NDC Directory

Ingredient names as written by FDA
BENDAMUSTINE HYDROCHLORIDE
Dosage forms
Injection, Injection, Powder, Lyophilized, For Solution, Injection, Solution
Routes
Intravenous
Manufacturers / labelers
12
Strengths listed
100 mg/1 · 100 mg/20ml · 100 mg/4ml · 25 mg/5ml · 25 mg/ml
Brand names in FDA listings
Belrapzo, Bendamustine, Bendeka, Treanda, Vivimusta

RxNorm (National Library of Medicine)

Ingredient concept RxCUI 134547

Drugs@FDA applications

Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.

ApplicationSponsorOriginal approvalListings
NDA 022249CEPHALON2008-03-202
NDA 208194EAGLE PHARMS2015-12-071
NDA 205580EAGLE PHARMS2018-05-151
ANDA 205574ACCORD HLTHCARE2022-12-073
NDA 212209AZURITY2022-12-072
NDA 215033APOTEX2022-12-071
NDA 216078BAXTER HLTHCARE CORP2022-12-151
ANDA 214739EUGIA PHARMA2023-06-052
ANDA 211001MEITHEAL2023-06-052
NDA 219014AVYXA HOLDINGS2025-07-031

Official labeling on DailyMed

Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.